Literature DB >> 17721024

Electrocardiographic and electrophysiologic characteristics in patients with Brugada type electrocardiogram and inducible ventricular fibrillation: single center experience.

Kimie Ohkubo1, Ichiro Watanabe, Yasuhiro Takagi, Yasuo Okumura, Sonoko Ashino, Masayoshi Kofune, Kazunori Kawauchi, Takeshi Yamada, Tatsuya Kofune, Kenichi Hashimoto, Atsushi Shindo, Hidezou Sugimura, Toshiko Nakai, Satoshi Saito, Atsushi Hirayama.   

Abstract

BACKGROUND: The study examined the electrocardiographic and electrophysiologic characteristics in relation to programmed ventricular stimulation (PVS)-induced ventricular fibrillation (VF) in patients with Brugada syndrome. METHODS AND
RESULTS: Thirty-four patients with a Brugada-type electrocardiogram (ECG) were enrolled. Twelve patients had a type 1 ECG, 12 had a type 2 ECG, and 10 had a type 3 ECG. PVS was performed with up to 2 ventricular premature beats from the right ventricular apex and outflow tract at 2 basic cycle lengths (600 and 400 ms). VF was induced in 17 of 23 (74%) asymptomatic patients and 10 of 11 (91%) symptomatic patients (p<0.05). The 27 patients in whom VF was induced by PVS and 7 patients without inducible VF were followed up for 47.1+/-33.7 months. One sudden death occurred during the follow-up period among asymptomatic patients with inducible VF, and no sudden death occurred among patients without inducible VF.
CONCLUSIONS: In conclusion, inducibility of ventricular arrhythmia is high in patients with Brugada syndrome, but it does not correlate with clinical presentation. Few arrhythmic events occur during follow up. However, the present study data suggest that electrophysiologic study-induced VF does not predict arrhythmic events during follow up.

Entities:  

Mesh:

Year:  2007        PMID: 17721024     DOI: 10.1253/circj.71.1437

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  5 in total

1.  Risk stratification [corrected] of Brugada syndrome revisited.

Authors:  Eyal Nof; Charles Antzelevitch
Journal:  Isr Med Assoc J       Date:  2008-06       Impact factor: 0.892

Review 2.  Genetic, molecular and cellular mechanisms underlying the J wave syndromes.

Authors:  Charles Antzelevitch
Journal:  Circ J       Date:  2012-04-11       Impact factor: 2.993

Review 3.  Brugada syndrome: recent advances and controversies.

Authors:  Charles Antzelevitch; Eyal Nof
Journal:  Curr Cardiol Rep       Date:  2008-09       Impact factor: 2.931

4.  Gender Differences in Prognosis and Risk Stratification of Brugada Syndrome: A Pooled Analysis of 4,140 Patients From 24 Clinical Trials.

Authors:  Mengchen Yuan; Chao Tian; Xinye Li; Xinyu Yang; Xiaofeng Wang; Yihan Yang; Nian Liu; Kengo F Kusano; Hector Barajas-Martinez; Dan Hu; Hongcai Shang; Yonghong Gao; Yanwei Xing
Journal:  Front Physiol       Date:  2018-08-22       Impact factor: 4.566

Review 5.  Programmed Ventricular Stimulation for Risk Stratification in the Brugada Syndrome: A Pooled Analysis.

Authors:  Jakub Sroubek; Vincent Probst; Andrea Mazzanti; Pietro Delise; Jesus Castro Hevia; Kimie Ohkubo; Alessandro Zorzi; Jean Champagne; Anna Kostopoulou; Xiaoyan Yin; Carlo Napolitano; David J Milan; Arthur Wilde; Frederic Sacher; Martin Borggrefe; Patrick T Ellinor; George Theodorakis; Isabelle Nault; Domenico Corrado; Ichiro Watanabe; Charles Antzelevitch; Giuseppe Allocca; Silvia G Priori; Steven A Lubitz
Journal:  Circulation       Date:  2016-01-21       Impact factor: 29.690

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.